論文（邦文）
- 前立腺癌
- 杉元幹史; 前立腺癌 今日の治療指針 私はこう治療している 2022 Vol.64 Page1236-1238
- 転移性尿路上皮癌の治療:Switch maintenance PD-L1
- 田岡利宜也, 杉元幹史; 西日本泌尿器科84(5)435-40,2022
- 【泌尿器科の疾患・治療・ケア】前立腺がん
- 土肥洋一郎; Uro-lo:泌尿器Care&Cure別冊 Page186-195
- 「会陰部の不快感」を訴える患者【慢性前立腺炎】
- 土肥洋一郎; Uro-lo:泌尿器Care&Cure Vol.27,Page67-71,2022
- Ⅳ. 高齢者悪性泌尿器疾患の病態と治療「前立腺癌に対する至適治療戦略」
- 土肥洋一郎, 杉元幹史; 日本臨床 80(6) 1021-1030 2022年6月
- 泌尿器科の疾患・治療・ケア:そのまんま使える患者説明ダウンロードシートつき
- 常森寛行（監修）; (泌尿器Care&Cure Uro-Lo 別冊 for nursing)メディカ出版 (2022.2.18)
- 抗悪性腫瘍薬（ホルモン療法薬－前立腺癌）
- 田岡利宜也, 筧善行; Pocket Drugs 2022 P576-580
- 泌尿器の解剖学的理解
- 岡添誉; レシピプラス2022夏号『尿のトラブル110番』南山堂 p9-15
- 尿が出すぎる！
- 内藤宏仁; レシピプラス2022夏号『尿のトラブル110番』南山堂 p34-37
- 尿がおかしい！
- 尾﨑悠; レシピプラス2022夏号『尿のトラブル110番』南山堂 p44-49
- 尿検査の種類と方法
- 松岡祐貴; レシピプラス2022夏号『尿のトラブル110番』南山堂 p54-60
- 検査ではなにを見ている？なにがわかる？
- 土肥洋一郎; レシピプラス2022夏号『尿のトラブル110番』南山堂 p61-67
- 腎カルチノイド乳房転移の1例(原著論文)
- 倉石佳奈, 紺谷桂一, 橋本新一郎, 法村尚子, 本城尚美, 大谷昌裕, 上田修史, 伊達学, 杉元幹史, 横見瀬裕; 乳癌の臨床(0911-2251)37巻1号 Page107-114(2022.03)
- PSA検診の有用性と過剰診断・過剰治療に対する対策～PSA検診にまつわる「そもそも」と「まっとう」を考える～
- 加藤琢磨, 杉元幹史; 西日本泌尿器科」第84巻4号 p.315-321
- 監視療法の適応・経過観察マーカーとしてのproPSAの意義
- 加藤琢磨, 杉元幹史; Prostate Journal Vol.9 No.2
- 監視療法の現状と近未来のあり方
- 加藤琢磨, 杉元幹史; 臨床泌尿器科 Vol.76. No.11
- 検査技師が泌尿器超音波検査を施行する効果について
- 田邊啓介, 打越彩, 芝直樹, 川田彩加, 清水美怜, 川渕幸映, 川崎有香, 津村香奈, 松下千明, 岡崎尚代, 真鍋友里, 横内美和子, 森規子, 末永武寛, 平間裕美, 岡添誉; 共済医報 第71巻第3号 245-249
論文（英文）
- Low quality of life in men with chronic prostatitis-like symptoms.
- Sugimoto M, Hijikata Y, Tohi Y, Kuroda H, Takei M, Matsuki T, Kamitani T, Kakehi Y, Yamamoto Y, Fukuhara S.; Prostate Cancer Prostatic Dis. 2022 Jun 25.
- Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional study.
- Sugimoto M, Kato T, Tohi Y, Shimizu Y, Matsumoto R, Inoue T, Takezawa Y, Masui K, Sasaki H, Hirama H, Saito S, Egawa S, Kamoto T, Teramukai S, Kojima S, Kikuchi T, Kakehi Y.; BMC Urol. 2022 Sep 14;22(1):151.
- The prevalence of gene mutations in homologous recombination repair pathways in Japanese patients with metastatic castration-resistant prostate cancer in real-world clinical practice: The multi-institutional observational ZENSHIN study.
- Uemura H, Oya M, Kamoto T, Sugimoto M, Shinozaki K, Morita K, Koto R, Takahashi M, Nii M, Shin E, Nonomura N.; Cancer Med. 2022 Nov 10.
- Narrative review of local prostate and metastasis-directed radiotherapy in the treatment of metastatic prostate cancer.
- Terada N, Aizawa R, Nihei K, Shiota M, Kojima T, Kimura T, Inoue T, Kitamura H, Sugimoto M, Nishiyama H, Mizowaki T, Kamoto T.; Jpn J Clin Oncol. 2022 May 31;52(6):633-641.
- Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium.
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer.
Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative. - Remmers S, Helleman J, Nieboer D, Trock B, Hyndman ME, Moore CM, Gnanapragasam V, Shiong Lee L, Elhage O, Klotz L, Carroll P, Pickles T, Bjartell A, Robert G, Frydenberg M, Sugimoto M, Ehdaie B, Morgan TM, Rubio-Briones J, Semjonow A, Bangma CH, Roobol MJ; Eur Urol Open Sci. 2022 Jun 14;41:126-133. doi:
- Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance GAP3 Consortium.
Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. - Olivier J, Li W, Nieboer D, Helleman J, Roobol M, Gnanapragasam V, Frydenberg M, Sugimoto M, Carroll P, Morgan TM, Valdagni R, Rubio-Briones J, Robert G, Stricker P, Hayen A, Schoots I, Haider M, Moore CM, Denton B, Villers A; Eur Urol Open Sci. 2022 Jan 3;35:59-67.
- Japanese Urological Oncology Group.
Cancer-specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapy. - Narita S, Terada N, Nomura K, Sakamoto S, Hatakeyama S, Kato T, Matsui Y, Inokuchi J, Yokomizo A, Tabata KI, Shiota M, Kimura T, Kojima T, Inoue T, Mizowaki T, Sugimoto M, Kitamura H, Kamoto T, Nishiyama H, Habuchi T; Int J Urol. 2022 Oct;29(10):1147-1154.
- Japanese Urological Oncology Group (JUOG).
Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burden. - Nagumo Y, Onozawa M, Kojima T, Terada N, Shiota M, Mitsuzuka K, Yasumoto H, Matsumoto H, Enokida H, Sugiyama T, Kuroiwa K, Saito T, Yokomizo A, Kohei N, Tabata KI, Takahashi A, Sugimoto M, Kitamura H, Kamoto T, Nishiyama H; Int J Urol. 2022 May;29(5):398-405.
- Olaparib in patients with mCRPC with homologous recombination repair gene alterations:PROfound Asian subset analysis.
- Matsubara N, Nishimura K, Kawakami S, Joung JY, Uemura H, Goto T, Kwon TG, Sugimoto M, Kato M, Wang SS, Pang ST, Chen CH, Fujita T, Nii M, Shen L, Dujka M, Hussain M, de Bono J.; Jpn J Clin Oncol. 2022 May 5;52(5):441-448.
- Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium.
Risk of progression following a negative biopsy in prostate cancer active surveillance. - Beckmann K, Santaolalla A, Sugimoto M, Carroll P, Rubio J, Villers A, Bjartell A, Morgan T, Dasgupta P, Van Hemelrijck M, Elhage O; Prostate Cancer Prostatic Dis. 2022 Aug 25.
- Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy.
- Akamatsu S, Terada N, Takata R, Kinoshita H, Shimatani K, Momozawa Y, Yamamoto M, Tada H, Kawamorita N, Narita S, Kato T, Nitta M, Kandori S, Koike Y, Inazawa J, Kimura T, Kimura H, Kojima T, Terachi T, Sugimoto M, Habuchi T, Arai Y, Yamamoto S, Matsuda T, Obara W, Kamoto T, Inoue T, Nakagawa H, Ogawa O.; JNCI Cancer Spectr. 2022 Jan 9;6(1):pkac001.
- Photodynamic diagnosis-assisted transurethral resection using oral 5-aminolevulinic acid decreases residual cancer and improves recurrence-free survival in patients with non-muscle-invasive bladder cancer
- Taoka R, Matsuoka Y, Yamasaki M, Kani N, Honda T, Harada S, Tohi Y, Kato T, Okazoe H, Tsunemori H, Ueda N, Sugimoto M; Photodiagnosis Photodyn Ther. 2022 Jun;38:102838.
- Editorial Comment to Substratification of patients with highest-risk non-muscle invasive bladder cancer helps to identify the candidates for immediate radical cystectomy: A two-center study
- Taoka R, Sugimoto M; Int J Urol . 2022 Sep;29(9):936-937.
- Editorial Comment from Dr Taoka and Dr Sugimoto to Real-world treatment patterns and clinical outcomes of Japanese patients with non-muscle invasive bladder cancer receiving intravesical bacillus Calmette-Guérin treatment
- Taoka R, Sugimoto M; Int J Urol . 2022 Oct;29(10):1130.
- Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer
- Murakami Y, Matsumoto K, Miyake M, Amano N, Shimura S, Nishimura N, Iida K, Matsushita Y, Abe T, Yamada T, Uemura M, Matsui Y, Taoka R, Kojima T, Kobayashi T, Nishiyama N, Kitamura H, Nishiyama H, Fujimoto K, Iwamura M.; Int J Urol. 2022 Oct;29(10):1195-1203.
- Japanese Urological Oncology Group.
Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data - Tomida R, Miyake M, Minato R, Sawada Y, Matsumura M, Iida K, Hori S, Fukui S, Ohyama C, Miyake H, Hongo F, Taoka R, Kobayashi T, Kojima T, Matsui Y, Nishiyama N, Kitamura H, Nishiyama H, Fujimoto K, Hashine K; Int J Clin Oncol. 2022 May;27(5):958-968.
- Prognostication in Japanese patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomy
- Nishimura N, Miyake M, Iida K, Miyamoto T, Tomida R, Numakura K, Inokuchi J, Yoneyama T, Matsumura Y, Yajima S, Masuda H, Terada N, Taoka R, Kobayashi T, Kojima T, Matsui Y, Nishiyama N, Kitamura H, Nishiyama H, Fujimoto K.; Int J Urol. 2022 Mar;29(3):242-249.
- C-reactive protein as a prognostic predictor for non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guérin therapy: A Japan Urological Oncology Group study analysis
- Ryoma Nishikawa, Makito Miyake, Shuichi Morizane, Ryutaro Shimizu, Shogo Teraoka, Masashi Honda, Kota Iida, Nobutaka Nishimura, Tomokazu Sazuka, Takahiro Kimura, Akihiro Ito, Kenichiro Shiga, Rikiya Taoka, Takahiro Kojima, Takashi Kobayashi, Naotaka Nishiyama, Hiroshi Kitamura, Hiroyuki Nishiyama, Kiyohide Fujimoto, Atsushi Takenaka; Int J Urol. 2022 Nov 30.
- The efficacy of sequential therapy with docetaxel and cabazitaxel for castration-resistant prostate cancer:A retrospective multi-institutional study in Japan.
- Terada N, Sawada A, Kawanishi H, Fujimoto T, Magaribuchi T, Chihara I, Hashimoto K, Sakurai T, Shimizu Y, Uegaki M, Nakashima M, Narita S, Kubota M, Yamada Y, Tohi Y, Okabe K, Yatsuda J, Kamoto T.; Int J Urol. 2022 Nov 14.
- Association of Increased Age With Decreased Response to Intravesical Instillation of Bacille Calmette-Guérin in Patients With High-Risk Non-Muscle Invasive Bladder Cancer: Retrospective Multi-Institute Results From theJapanese Urological Oncology Research Group JUOG-UC-1901-BCG
- Inoue T, Miyake M, Nishimura N, Onozawa M, Kashima S, Numakura K, Narita S, Iida K, Uemura M, Matsushita Y, Inokuchi J, Matsui Y, Taoka R, Kojima T, Kobayashi T, Nishiyama N, Kitamura H, Nishiyama H, Fujimoto K, Habuchi T.; Urology. 2022 Sep;167:158-164.
- Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN study.
- Kato T, Yokomizo A, Matsumoto R, Tohi Y, Miyakawa J, Mitsuzuka K, Sasaki H, Inokuchi J, Matsumura M, Sakamoto S, Kinoshita H, Fukuhara H, Kamiya N, Kimura R, Nitta M, Okuno H, Akakura K, Kakehi Y, Sugimoto M.; Int J Urol. 2022 Jul 19.
- A National Questionnaire Survey of Japanese Urologists on Active Surveillance for Low- and Intermediate-Risk Prostate Cancer
- Takuma Kato, Yoichiro Tohi, Tomoko Hondaa, Iori Matsuda, Yu Osaki, Hirohito Naito, Yuki Matsuoka, Homare Okazoe, Rikiya Taoka, Hiroyuki Tsunemori, Nobufumi Ueda, Mikio Sugimoto.; International Journal of Urology; 2022 Nov 22
- Management of prostate cancer in older patients
- Shintaro Narita, Shingo Hatakeyama, Shinichi Sakamoto, Takuma Kato, Juichi Inokuchi, Yoshiyuki Matsui, Hiroshi Kitamura, Hiroyuki Nishiyama, Tomonori, Habuchi; Jpn J Clin Oncol. 2022 May 31;52(6):513-525.
- Japanese Urological OncologyGroup.
Radiotherapy plus androgen deprivation therapy for prostate-specific antigen persistence in lymph node-positive prostate cancer. - Shiota M, Takamatsu D, Kimura T, Tashiro K, Matsui Y, Tomida R, Saito R, Tsutsumi M, Yokomizo A, Yamamoto Y, Edamura K, Miyake M, Morizane S, Yoshino T, Matsukawa A, Narita S, Matsumoto R, Kasahara T, Hashimoto K, Matsumoto H, Kato M, Akamatsu S, Joraku A, Kato M, Yamaguchi T, Saito T, Kaneko T, Takahashi A, Kato T, Sakamoto S, Enokida H, Kanno H, Terada N, Suekane S, Nishiyama N, Eto M, Kitamura H; Cancer Sci. 2022 Jul;113(7):2386-2396.
- Impact of the severity of urethrovesical anastomotic leakage on urinary continence following robot-assisted laparoscopic prostatectomy.
- Tohi Y, Kohashiguchi K, Miura T, Miyauchi Y, Matsuoka Y, Kato T, Taoka R, Tsunemori H, Ueda N, Sugimoto M.; J Robot Surg. 2022 Oct;16(5):1175-1181.
- The Paris System for reporting urinary cytology improves the negative predictive value of high-grade urothelial carcinoma.
- Yamasaki M, Taoka R, Katakura K, Matsunaga T, Kani N, Honda T, Harada S, Tohi Y, Matsuoka Y, Kato T, Okazoe H, Tsunemori H, Ueda N, Haba R, Sugimoto M.; BMC Urol. 2022 Apr 5;22(1):51.
- Impact of adherence to criteria on oncological outcomes of radical prostatectomy in patients opting for active surveillance: data from the PRIAS-JAPAN study.
- Tohi Y, Kato T, Miyakawa J, Matsumoto R, Sasaki H, Mitsuzuka K, Inokuchi J, Matsumura M, Yokomizo A, Kinoshita H, Hara I, Kawamura N, Hashimoto K, Inoue M, Teishima J, Kanno H, Fukuhara H, Maruyama S, Sakamoto S, Saito T, Kakehi Y, Sugimoto M.; Jpn J Clin Oncol. 2022 Sep 18;52(9):1056-1061.
- Chu-shikoku Japan Urological Consortium.
Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium. - Tohi Y, Kato T, Fukuhara H, Kobayashi K, Ohira S, Ikeda K, Daizumoto K, Katayama S, Shimizu R, Nishimura K, Nagami T, Hayashida Y, Hirama H, Takamoto A, Dainichi T, Sugimoto M; Int J Clin Oncol. 2022 Aug;27(8):1348-1355.
- Project to Develop a Novel Diagnostic Tool for Chronic Prostatitis. Successful establishment of crowdfunding to develop new diagnostic tools for chronic prostatitis.
- Tohi Y, Kakehi Y, Sugimoto M; Int J Urol. 2022 Jun;29(6):600-602.
- Antitumor Effects of Orally Administered Rare Sugar D-Allose in Bladder Cancer.
- Tohi Y, Taoka R, Zhang X, Matsuoka Y, Yoshihara A, Ibuki E, Haba R, Akimitsu K, Izumori K, Kakehi Y, Sugimoto M.; Int J Mol Sci. 2022 Jun 17;23(12):6771.
- Effect of continued perioperative antithrombotic therapy on bleeding outcomes following laparoscopic nephrectomy and nephroureterectomy.
- Kubota M, Matsuoka T, Mine Y, Hagimoto H, Kokubun H, Murata S, Makita N, Hattori Y, Suzuki I, Abe Y, Tohi Y, Tsutsumi N, Yamasaki T, Inoue K, Kawakita M.; Asian J Endosc Surg. 2022 Jul 4.
- Surgical and functional outcomes of robot-assisted versus laparoscopic partial nephrectomy with cortical renorrhaphy omission.
- Kubota M, Yamasaki T, Murata S, Abe Y, Tohi Y, Mine Y, Hagimoto H, Kokubun H, Suzuki I, Tsutsumi N, Inoue K, Kawakita M.; Sci Rep. 2022 Jul 29;12(1):13000.
- Immune-related adverse events in urothelial cancer patients: Adjustment for immortal time bias
- Hikari Otsuka, Yuki Kita, Katsuhiro Ito, Takeshi Sano, Junichi Inokuchi, Ryotaro Tomida, Atsushi Takahashi, Kazumasa Matsumoto, Ryoma Kurahashi, Yu Osaki, Masayuki Uegaki, Satoru Maruyama, Shoichiro Mukai, Masakazu Tsutsumi, Takashi Kawahara, Takehiko Segawa, Hiroshi Kitamura, Satoshi Morita, Takashi Kobayashi; Cancer Sci. 2022 Nov;113(11):3912-3921.
- Acute generalized exanthematous pustulosis during apalutamide treatment in a patient with prostate cancer.
- Honda T, Tohi Y, Kaku Y, Kimura N, Kato T, Haba R, Dainichi T, Sugimoto M.; IJU Case Rep. 2022 Aug 16;5(6):497-500.